Abstract:Study question: What is the transcriptional network governed by the androgen receptor (AR) in human epididymis epithelial (HEE) cells from the caput region and if the network is tissue-specific, how is this achieved? Summary answer: About 200 genes are differentially expressed in the caput HEE cells after AR activation; the AR transcriptional network is tissue-specific and may be mediated in part by distinct AR co-factors including CAAT-enhancer binding protein beta (CEBPB) and runt-related transcription factor 1 (RUNX1). What is known already: Little is known about the AR transcriptional program genome wide in HEE cells, nor its co-factors in those cells. AR has been best studied in the prostate gland epithelium and prostate cancer cell lines, due to the important role of this factor in prostate cancer. However AR-associated differentially expressed genes (DEGs) and AR co-factors have not yet been compared between human epididymis and prostate epithelial cells. Study design, size, duration: Caput HEE cells from two donors were exposed to the synthetic androgen R1881 at 1 nM for 12-16 h after 72 h of hormone starvation. Participants/materials, setting, methods: Chromatin was prepared from R1881-treated and vehicle control HEE cells. AR-associated chromatin was purified by chromatin immunoprecipitation (ChIP) and AR occupancy genome wide was revealed by deep sequencing (ChIP-seq). Two independent biological replicates were performed. Total RNA was prepared from R1881 and control-treated HEE cells and gene expression profiles were documented by RNA-seq. The interaction of the potential novel AR co-factors CEBPB and RUNX1, identified through in-silico motif analysis of AR ChIP-seq data, was examined by ChIP-qPCR after siRNA-mediated depletion of each co-factor individually or simultaneously. Main results and the role of chance: The results identify about 200 genes that are differentially expressed (DEGs) in HEE cells after AR activation. Some of these DEGs show occupancy of AR at their promoters or cis-regulatory elements suggesting direct regulation. However, there is little overlap in AR-associated DEGs between HEE and prostate epithelial cells. Inspection of over-represented motifs in AR ChIP-seq peaks identified CEBPB and RUNX1 as potential co-factors, with no evidence for FOXA1, which is an important co-factor in the prostate epithelium. CEBPB and RUNX1 ChIP-seq in HEE cells showed that both these factors often occupied AR-binding sites, though rarely simultaneously. Further analysis at a single AR-regulated locus (FK506-binding protein 5, FKPB5) suggests that CEBPB may be a co-activator. These data suggest a novel AR transcriptional network governs differentiated functions of the human epididymis epithelium. Large scale data: AR ChIP-seq and RNA-seq data are deposited at GEO: GSE109063. Limitations, reasons for caution: There is substantial donor-to-donor variation in primary HEE cells cultures. We applied stringent statistical tests with a false discovery rate (FDR) of 0.1% for ChIP-seq and standard pipelines for RNA-seq so it is possible that we have missed some AR-regulated genes that are important in caput epididymis function. Wider implications of the findings: Our data suggest that a novel AR transcriptional network governs differentiated functions of the human epididymis epithelium. Since this cell layer has a critical role in normal sperm maturation, the results are of broader significance in understanding the mechanisms underlying the maintenance of fertility in men. Study funding/competing interests: This work was funded by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development: R01 HD068901 (PI: Harris). The authors have no competing interests to declare.

Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis

The regulation of β-catenin activity and function in cancer: therapeutic opportunities

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Wnt/β-catenin signalling in prostate cancer

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance

β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy

Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis

Belling the "cat": Wnt/β-catenin signaling and its significance in future cancer therapies

Extracellular vesicles are involved in the paracrine communication between epithelial cells in different regions of the domestic cat epididymis

Targeting the β-catenin signaling for cancer therapy

A novel transcriptional network for the androgen receptor in human epididymis epithelial cells

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers